- cafead Aug 28, 2018 at 10:22: AM
via After 16 years as a public company, Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) finally got the go-ahead to launch its first product earlier this month. Onpattro is the first in a new class of drugs that alter gene expression, but Pfizer, Inc. (NYSE
FE) just reported some impressive results with a possible competitor that works a lot differently.
article source
FE) just reported some impressive results with a possible competitor that works a lot differently.article source